Nicergoline enhances glutamate uptake via glutamate transporters in rat cortical synaptosomes

Biological and Pharmaceutical Bulletin

Volumn 27, Issue 6, 2004, Pages 817-820

  Nishida, Atsushi ^a   Iwata, Hiroshi ^a   Kudo, Yukitsuka ^b   Kobayashi, Tsutomu ^a   Matsuoka, Yuzo ^a   Kanai, Yoshikatsu ^c   Endou, Hitoshi ^c  

^a MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^c KYORIN UNIVERSITY   (Japan)

Author keywords

Glutamate reversed transport; Glutamate transporter; Glutamate uptake; Nicergoline; Synaptosome; Xenopus oocyte

Indexed keywords

DIHYDROKAINIC ACID; GLUTAMATE TRANSPORTER; GLUTAMIC ACID; NICERGOLINE; SODIUM; UNCLASSIFIED DRUG; VESICULAR GLUTAMATE TRANSPORTER 1;

AMINO ACID TRANSPORT; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN SYNAPTOSOME; CONCENTRATION (PARAMETERS); DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; EXTRACELLULAR MATRIX; FEMALE; GLIA; MALE; MOLECULAR CLONING; NEUROPROTECTION; NONHUMAN; OOCYTE; PROTEIN EXPRESSION; RAT; XENOPUS; ANIMAL; COMPARATIVE STUDY; DOSE RESPONSE; METABOLISM; SYNAPTOSOME; WISTAR RAT; XENOPUS LAEVIS;

AMINO ACID TRANSPORT SYSTEM X-AG; ANIMALS; CEREBRAL CORTEX; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLUTAMIC ACID; MALE; NICERGOLINE; RATS; RATS, WISTAR; SYNAPTOSOMES; XENOPUS LAEVIS;

EID: 16644394840     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.27.817     Document Type: Article

References (40)

1. Bouvier M., Szatkowski M., Amato A., Attwell D., Nature (London), 360, 471-474 (1992).
2. Kanai Y., Hediger M. A., Nature (London), 360, 467-471 (1992).
3. Kanai Y., Smith C. P., Hediger M. A., Trends Neurosci., 16, 365-370 (1993).
4. Kawakami H., Tanaka K., Nakayama T., Inoue K., Nakamura S., Biochem. Biophys. Res. Commun., 199, 171-176 (1994).
5. Pines G., Danbolt N. C., Bjoras M., Zhang Y., Bendahan A., Eide L., Koepsell H., Storm-Mathisen J., Seeberg E., Kanner B. I., Nature (London), 360, 464-467 (1992).
6. Robinson M. B., Hunter-Ensor M., Sinor J., Brain Res., 544, 196-202 (1991).
7. Tanaka K., Neurosci. Res., 16, 149-153 (1993).
8. Tanaka K., Neurosci. Lett., 159, 183-186 (1993).
9. Rothstein J. D., Martin L. J., Kuncl R. W., New Engl. J. Med., 326, 1464-1468 (1992).
10. Li S., Mallory M., Alford M., Tanaka S., Masliah E., J. Neuropathol. Exp. Neurol., 56, 901-911 (1997).
11. Palmer A. M., Proctor A. W., Stratmann G. C., Bowen D. M., Neurosci. Lett., 66, 199-204 (1986).
12. Attwell D., Barbour B., Szatkowski M., Neuron, 11, 401-407 (1993).
13. Kanai Y., Stelzner M., Nussberger S., Khawaja S., Hebert S. C., Smith C. P., Hediger M. A., J. Biol. Chem., 269, 20599-20606 (1994).
14. Levi G., Raiteri M., Trends Neurosci., 16, 415-419 (1993).
15. Yamashita H., Kawakami H., Zhang Y., Tanaka K., Nakamura S., Lancet, 346, 1305 (1995).
16. Heitz C., Descombes J. J., Miller R. C., Stoclet J. C., Eur. J. Pharmacol., 123, 279-285 (1986).
17. Iwata E., Miyazaki I., Asanuma M., Iida A., Ogawa N., Neurosci. Lett., 251, 49-52 (1998).
18. LePoncin-Lafitte M., Grosdemouge C., Duterte D., Rapin J. R., Gerontology, 30, 109-119 (1984).
19. Shintomi K., Egou H., Tanaka T., Itakura T., Yoshimoto K., Matsumoto M., Matsuoka Y., Folia Pharmacol. Japon, 87, 445-456 (1986).
20. Shintomi K., Itakura T., Yoshimoto K., Ogawa Y., Fukushima T., Matsuoka Y., Folia Pharmacol. Japon, 87, 427-434 (1986).
21. Shintomi K., Ogawa Y., Yoshimoto K., Narita H., Folia Pharmacol. Japon, 87, 537-549 (1986).
22. Shintomi K., Arzheim.-Forsch. Drug Res., 41, 885-890 (1991).
23. Takahashi K., Akaike N., Br. J. Pharmacol., 100, 705-710 (1990).
24. Tanaka M., Yoshida T., Okamoto K., Hirai S., Neurosci. Lett., 248, 68-72 (1998).
25. Carfagna N., Diclemente A., Cavanus S., Damiani D., Gerna M., Salmoiraghi P., Cattaneo B., Post C., Neurosci. Lett., 197, 195-198 (1995).
26. Kudo Y., Egou H., Ishida R., Jpn. Pharmacol. Ther., 13, 6489-6493 (1985).
27. Ogawa N., Mizukawa K., Haba K., Asanuma M., Geriat. Med., 27, 1198-1204 (1989).
28. Ogawa N., Asanuma M., Hirata H., Kondo Y., Kawada Y., Mori A., Arch. Geront. Geriatr., 16, 103-110 (1993).
29. Moretti A., Carfagna N., Caccia C., Carpentieri M., Arch. Int. Pharmacodyn. Ther., 294, 33-45 (1988).
30. Iwasaki H., Jpn. Pharmacol. Ther., 18, 1995-2004 (1990).
31. Asai S., Zhao H., Yamashita A., Jike T., Kunimatsu T., Nagata T., Kohno T., Ishikawa K., Eur. J. Pharmacol., 383, 267-274 (1999).
32. Nishida A., Kobayashi T., Kudo Y., Matsuoka Y., Jpn. J. Pharmacol. (Suppl. 1), 76, 85P (1998).
33. Hajos F., Brain Res., 93, 485-489 (1975).
34. Allen J. W., Shanker G., Aschner M., Brain Res., 894, 131-140 (2001).
35. Graham L. T., Jr., Aprison M. H., Anal. Biochem., 15, 487-497 (1966).
36. Chatton J. Y., Shimamoto K., Magistretti P. J., Brain Res., 893, 46-52 (2001).
37. Kanai Y., Curr. Opin. Cell Biol., 9, 565-572 (1997).
38. Yamashita H., Kawakami H., Zhang Y. X., Tanaka K., Nakamura S., J. Neurol. Sci., 155, 31-36 (1998).
39. Nakayama T., Kawakami H., Tanaka K., Nakamura S., Brain Res. Mol. Brain Res., 36, 189-192 (1996).
40. Lin C. I., Orlov I., Ruggiero A. M., Dykes-Hoberg M., Lee A., Jackson M., Rothstein J. D., Nature (Londond), 410, 84-88 (2001).